523031 — ADS Diagnostic Income Statement
0.000.00%
HealthcareMicro Cap
Annual income statement for ADS Diagnostic, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 143 | 106 | 104 | 138 | 241 |
Cost of Revenue | |||||
Gross Profit | 54.3 | 51.6 | 59.8 | 70.4 | 120 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 132 | 96.2 | 93.8 | 129 | 210 |
Operating Profit | 11 | 10 | 10.3 | 8.91 | 30.7 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6.2 | 4.42 | 5.64 | 4.86 | 25 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4.71 | 3.37 | 4.4 | 4.06 | 18.5 |
Net Income Before Extraordinary Items | |||||
Net Income | 4.71 | 3.37 | 4.4 | 4.06 | 18.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4.71 | 3.37 | 4.4 | 4.06 | 18.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.15 | 1.53 | 1.86 | 5.11 | 8.44 |
Dividends per Share |